This edited book offers a comprehensive exploration of urological cancers, focusing on the pathophysiology and the promising role of phytochemicals in therapeutic interventions. It provides an in-depth understanding of the molecular characterization, risk factors, and progression of these cancers, alongside cutting-edge diagnostic methods. The chapters explore key topics such as the tumor microenvironment, recent advances in detection, and the mechanistic insights of anticancer phytochemicals. The book bridges ancient remedies with contemporary pharmacological developments, emphasizing alternative therapies and the challenges in drug discovery. It also delves into the role of long non-coding RNA biology, targeted nanoformulations, and the current state of clinical trials, offering a holistic view of the field. This volume is an invaluable resource for researchers, clinical oncologists, and students in the field of urological cancer biology. It offers a concise yet comprehensive guide to the latest advancements and challenges in the field, making it an essential read for those involved in precision medicine and drug development.